CAMBRIDGE, Mass. — NextCODE Health, which puts whole-genome analysis in the hands of clinicians and researchers worldwide, today announced the start of a partnership with the Academic Centre on Rare Diseases (ACoRD) at University College Dublin. ACoRD will use NextCODE solutions to take full advantage of the latest sequencing technologies to improve the diagnosis and […]

OMAHA, Neb. — Transgenomic, Inc. (NASDAQ: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services, today announced that it has entered into an agreement to sell to Integrated DNA Technologies, Inc. (IDT) the rights to Transgenomic’s SURVEYOR Nuclease technology and assets […]

CORALVILLE, IA – – Integrated DNA Technologies (IDT) has acquired the SURVEYOR® enzyme business of Transgenomic, Inc. Already the world leader in custom nucleic acid synthesis, IDT is expanding its molecular biology product offerings by adding the SURVEYOR enzyme and kits. As part of the agreement with Transgenomic, IDT will acquire the SURVEYOR product line […]

Basel — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the launch of cobas® 6500, a fully automated urine testing system that consists of two modular analyzers combining urine strip testing and digital urinary microscopy. The system tests for 23 parameters to help diagnose diseases such as urinary tract infection, kidney disease, and diabetes. The […]

SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) today announced that it has entered into separate agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsried, under which they will use the HiSeq 2500 and consumables from Illumina to develop and perform non-invasive prenatal testing (NIPT). Biomnis plans to make NIPT available in […]

BETHLEHEM, Pa.– OraSure Technologies (Nasdaq:OSUR), a market leader in point of care diagnostics, announced today continued progress under its agreement with Thermo Fisher Scientific (Thermo Fisher) to develop and supply homogenous fully-automated oral fluid drugs of abuse assays to be used with a new version of the Company’s Intercept® oral fluid specimen collection device. The […]

BILLERICA, Mass.– Bruker Corporation (NASDAQ: BRKR) today announced that it has received clearance from the China Food and Drug Administration (CFDA) to market and sell its IVD MALDI Biotyper System as a medical device in China for the identification of microorganisms isolated from human specimens. MALDI Biotyper-based microbial identification has major advantages compared to classical […]

Manassas, VA — ATCC, the premier global biological materials resource and standards organization, has licensed technology from the Centers for Disease Control and Prevention (CDC) and partnered with Thermo Fisher Scientific to bring a rapid and cost-effective PCR-based method of monitoring HIV drug resistance to resource-limited countries. The ATCC® HIV-1 Drug Resistance Genotyping Kit was […]

CAMBRIDGE, Mass.– NextCODE Health today announced that a team at the ANZAC Research Institute in Sydney, Australia have used NextCODE capabilities to home in on novel sequence variants underlying X-linked Charcot-Marie-Tooth syndrome (CMTX). CMTX is a rare and progressively debilitating neurodegenerative disorder. It tends to manifest itself in childhood and can be caused by mutations […]